Hubert Allen - Abbott Laboratories Gen VP
| ABL Stock | EUR 125.50 1.62 1.31% |
Insider
Hubert Allen is Gen VP of Abbott Laboratories
| Age | 57 |
| Phone | 224 667 6100 |
| Web | https://www.abbott.com |
Hubert Allen Latest Insider Activity
Tracking and analyzing the buying and selling activities of Hubert Allen against Abbott Laboratories stock is an integral part of due diligence when investing in Abbott Laboratories. Hubert Allen insider activity provides valuable insight into whether Abbott Laboratories is net buyers or sellers over its current business cycle. Note, Abbott Laboratories insiders must abide by specific rules, including filing SEC forms every time they buy or sell Abbott Laboratories'shares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Hubert Allen over a month ago Disposition of 131360 shares by Hubert Allen of Abbott Laboratories at 38.4 subject to Rule 16b-3 |
Abbott Laboratories Management Efficiency
The company has return on total asset (ROA) of 0.0738 % which means that it generated a profit of $0.0738 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1901 %, meaning that it generated $0.1901 on every $100 dollars invested by stockholders. Abbott Laboratories' management efficiency ratios could be used to measure how well Abbott Laboratories manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 10 records | INSIDER Age | ||
| Richard III | Laureate Education | 53 | |
| Leslie Brush | Laureate Education | N/A | |
| Marcelo Cardoso | Laureate Education | 51 | |
| Richard Buskirk | Laureate Education | 46 | |
| Adam Morse | Laureate Education | N/A | |
| Minghua Cai | Yuexiu Transport Infrastructure | 44 | |
| Eilif SerckHanssen | Laureate Education | 57 | |
| Luis Novelo | Laureate Education | N/A | |
| Adam Smith | Laureate Education | N/A | |
| Gerard Knauer | Laureate Education | 47 | |
Management Performance
| Return On Equity | 0.19 | |||
| Return On Asset | 0.0738 |
Abbott Laboratories Leadership Team
Elected by the shareholders, the Abbott Laboratories' board of directors comprises two types of representatives: Abbott Laboratories inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Abbott. The board's role is to monitor Abbott Laboratories' management team and ensure that shareholders' interests are well served. Abbott Laboratories' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Abbott Laboratories' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Scott Leinenweber, Licensing Relations | ||
| Robert Ford, Pres Chairman | ||
| James Young, VP Officer | ||
| Elaine Leavenworth, VP Officer | ||
| Mary Moreland, Ex HR | ||
| Robert Funck, Exec CFO | ||
| Daniel Salvadori, Ex Products | ||
| Andrea Wainer, Ex Diagnostics | ||
| Hubert Allen, Gen VP | ||
| Melissa Brotz, VP Marketing |
Abbott Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Abbott Laboratories a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.19 | |||
| Return On Asset | 0.0738 | |||
| Profit Margin | 0.16 % | |||
| Operating Margin | 0.20 % | |||
| Current Valuation | 190.22 B | |||
| Shares Outstanding | 1.74 B | |||
| Shares Owned By Insiders | 0.70 % | |||
| Shares Owned By Institutions | 76.37 % | |||
| Price To Earning | 41.25 X | |||
| Price To Book | 5.40 X |
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Abbott Stock
When determining whether Abbott Laboratories is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Abbott Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Abbott Laboratories Stock. Highlighted below are key reports to facilitate an investment decision about Abbott Laboratories Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Abbott Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more detail on how to invest in Abbott Stock please use our How to Invest in Abbott Laboratories guide.You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.